Share this video  

VJHemOnc is committed to improving our service to you

MPN Congress 2022 | Topics in CML: drug therapy revisited, third-line treatment, TFR update

Rüdiger Hehlmann, MD, PhD, Heidelberg University, Heidelberg, Germany, gives a presentation on advances in treatments for chronic myeloid leukemia (CML), managing CML in the third-line setting, and tyrosine kinase discontinuation (TKI) at the 14th International Congress on Myeloproliferative Neoplasms (MPNs) held in New York City, NY.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter